Human Growth Hormone

Human Growth Hormone

• Home
• What is HGH?
• Search
• Syndicate
• More Health

See Also

Human Growth Hormone > Somatropin > Cambridge

Please select a HGH news story from the list below:

• Biotech Business - ALTUS GETS POSITIVE RESULTS FROM ONCE-PER-WEEK GROWTH HORMONE.
• Business Wire - Altus Pharmaceuticals Announces Positive Results from Phase II Study in Growth Hormone Deficient Patients with Once-Per-Week Growth Hormone
• Business Wire - Altus Pharmaceuticals Presents Positive Data from Phase I Study of ALTU-238; First Patients Dosed in Phase II Trial in Adults with Growth Hormone Deficiency
• Business Wire - Altus Pharmaceuticals Announces Completion of Clinical Testing in the Phase I Study of ALTU-238 - a Long-Acting Crystalline Formulation of Human Growth Hormone
• Business Wire - Genentech Corrects and Replaces Previous Genentech and Alkermes Announcment, BW0172 CA-GENENTECH/ALKERMES
• M2 Presswire - Nutropin Depot, first long-acting dosage form of recombinant growth hormone, now available.
• Business Wire - Nutropin Depot, First Long-Acting Dosage Form of Recombinant Growth Hormone, Now Available
• M2 Presswire - US FDA: FDA approves Nutropin Depot, first lo long-acting dosage form of recombinant growth hormone.
• Chemical Market Reporter - GENETECH.(Genetach Inc. will file application for new drug with Federal Drug Administration )

Biotech Business - ALTUS GETS POSITIVE RESULTS FROM ONCE-PER-WEEK GROWTH HORMONE.

August 1, 2006 -- Altus Pharmaceuticals Inc. (Nasdaq: ALTU), Cambridge, Mass. a biopharmaceutical company focused on the development and commercialization of oral...

• Biotech Business - ALTUS GETS POSITIVE RESULTS FROM ONCE-PER-WEEK GROWTH HORMONE.

Business Wire - Altus Pharmaceuticals Announces Positive Results from Phase II Study in Growth Hormone Deficient Patients with Once-Per-Week Growth Hormone

June 23, 2006 -- CAMBRIDGE, Mass. -- Altus Pharmaceuticals Inc. (Nasdaq: ALTU), a biopharmaceutical company focused on the development and commercialization of oral...

• Business Wire - Altus Pharmaceuticals Announces Positive Results from Phase II Study in Growth Hormone Deficient Patients with Once-Per-Week Growth Hormone

Business Wire - Altus Pharmaceuticals Presents Positive Data from Phase I Study of ALTU-238; First Patients Dosed in Phase II Trial in Adults with Growth Hormone Deficiency

September 28, 2005 -- CAMBRIDGE, Mass. -- Altus(R) Pharmaceuticals Inc., a company which is developing protein therapies to treat gastrointestinal and metabolic diseases,...

• Business Wire - Altus Pharmaceuticals Presents Positive Data from Phase I Study of ALTU-238; First Patients Dosed in Phase II Trial in Adults with Growth Hormone Deficiency

Business Wire - Altus Pharmaceuticals Announces Completion of Clinical Testing in the Phase I Study of ALTU-238 - a Long-Acting Crystalline Formulation of Human Growth Hormone

June 6, 2005 -- CAMBRIDGE, Mass. -- Plans to Initiate Phase II Multi-Center Trial in Adults with Growth Hormone Deficiency Altus(R) Pharmaceuticals Inc., a leader...

• Business Wire - Altus Pharmaceuticals Announces Completion of Clinical Testing in the Phase I Study of ALTU-238 - a Long-Acting Crystalline Formulation of Human Growth Hormone

Business Wire - Genentech Corrects and Replaces Previous Genentech and Alkermes Announcment, BW0172 CA-GENENTECH/ALKERMES

January 8, 2001 -- Business Editors NOTE: The following news release replaces and corrects the previous Genentech news release, which ran earlier Monday on...

• Business Wire - Genentech Corrects and Replaces Previous Genentech and Alkermes Announcment, BW0172 CA-GENENTECH/ALKERMES

M2 Presswire - Nutropin Depot, first long-acting dosage form of recombinant growth hormone, now available.

June 29, 2000 -- M2 PRESSWIRE-29 June 2000-GENENTECH: Nutropin Depot, first long-acting dosage form of recombinant growth hormone, now available (C)1994-2000 M2...

• M2 Presswire - Nutropin Depot, first long-acting dosage form of recombinant growth hormone, now available.

Business Wire - Nutropin Depot, First Long-Acting Dosage Form of Recombinant Growth Hormone, Now Available

June 28, 2000 -- Business Editors and Health/Medical Writers SOUTH SAN FRANCISCO, Calif. and CAMBRIDGE, Mass.--(BW HealthWire)--June 28, 2000--Genentech, Inc....

• Business Wire - Nutropin Depot, First Long-Acting Dosage Form of Recombinant Growth Hormone, Now Available

M2 Presswire - US FDA: FDA approves Nutropin Depot, first lo long-acting dosage form of recombinant growth hormone.

December 24, 1999 -- M2 PRESSWIRE-24 December 1999-US FDA: FDA approves Nutropin Depot, first long-acting dosage form of recombinant growth hormone for growth hormone...

• M2 Presswire - US FDA: FDA approves Nutropin Depot, first lo long-acting dosage form of recombinant growth hormone.

Chemical Market Reporter - GENETECH.(Genetach Inc. will file application for new drug with Federal Drug Administration )

November 2, 1998 -- GENETECH Inc. will proceed with plans early next year to submit a new drug application with FDA for Nutropin Depot, a sustained release formulation...

• Chemical Market Reporter - GENETECH.(Genetach Inc. will file application for new drug with Federal Drug Administration )

Cities

cambridge south san francisco

Province/States

california massachusetts

Industry Term

biopharmaceutical